Boman, Caroline http://orcid.org/0000-0003-1663-6129
Edman Kessler, Luisa
Bergh, Jonas
Matikas, Alexios
Foukakis, Theodoros
Funding for this research was provided by:
Cancerfonden (CAN 2018/846)
Stockholms Läns Landsting
Karolinska Institute
Article History
Received: 25 November 2021
Accepted: 28 March 2022
First Online: 24 April 2022
Declarations
:
: Caroline Boman and Luisa Edman Kessler have no conflicts of interest to disclose. Jonas Bergh received research funding from Merck paid to Karolinska Institutet and from Amgen, Bayer, Pfizer, Roche, and Sanofi-Aventis paid to Karolinska University Hospital. No personal payments. Payment from UpToDate for two chapters in breast cancer prediction paid to Asklepios Medicine HB. Alexios Matikas was a consultant to Veracyte, CA, USA (no financial compensation). Theodoros Foukakis received institutional grants from Roche and Pfizer and personal fees from Affibody, Novartis, Pfizer, Roche, Exact Sciences, Veracyte, and UpToDate.
: The study was approved by the ethics committee in Stockholm (decision number 2016/1303/31 and 2018/642-32). No animal experiments were performed.
: No informed consent was needed for this registry-based study as per the ethics committee in Stockholm (decision number 2016/1303/31 and 2018/642–32).
: Not applicable.